SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-020957
Filing Date
2023-04-27
Accepted
2023-04-27 16:19:51
Documents
4
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20008153x1_def14a.htm DEF 14A 573911
2 logo_compasstherapeutics.jpg GRAPHIC 52578
3 ny20008153x1_pc01.jpg GRAPHIC 633689
4 ny20008153x1_pc02.jpg GRAPHIC 465895
  Complete submission text file 0001140361-23-020957.txt   2160960
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39696 | Film No.: 23857274
SIC: 2836 Biological Products, (No Diagnostic Substances)